Deadly brain cancer shrinks after CAR-T therapy — but for how long is unclear
Nature, Published online: 13 March 2024; doi:10.1038/d41586-024-00704-6Early studies with engineered immune cells show dramatic but often short-lived results in glioblastoma, the most aggressive brain cancer.
Nature, Published online: 13 March 2024; doi:10.1038/d41586-024-00704-6
What's Your Reaction?